support the research and development of vaccines and medicines for the communicable and non communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the doha declaration on the trips agreement and public health, which affirms the right of developing countries to use to the full the provisions in the agreement on trade related aspects of intellectual property rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all. proportion of the population with access to affordable medicines and vaccines on a sustainable basis. total net official development assistance to medical research and basic health sectors. substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing states. while needs are being addressed gradually, more than 225 million women have an unmet need for contraception. goal 3 aims to achieve universal health coverage, including access to essential medicines and vaccines. it proposes to end the preventable death of newborns and children under 5 and to end epidemics such as aids, tuberculosis, malaria, and water borne diseases, for example. 2016 rates for the third dose of the pertussis vaccine (dtp3) and the first dose of the measles vaccine (mcv1) reached 86 percent and 85 percent, respectively. yet about 20 million children did not receive dtp3 and about 21 million did not receive mcv1. around 2 in 5 countries will need to accelerate progress in order to reach sdg targets for immunization. 